Chinese medical-device company; specific product focus not independently confirmed with confidence.
Chinese medical-device company; specific product focus not independently confirmed with confidence.
Moat: none
Headquarters: China · Employees: 1,057
Size Caina Technology (301122.SZ) is a China Health Care company (Medical Specialties) with a market value of $721M, the 2836th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥42.48 on 18 Nov 2026.
Performance Over six months the shares gained 36.5%, against -17.5% for the median peer and -20.0% for the China market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue grew 61.4% over the last twelve months (peer median +14.8%); the operating margin is 0.3% (peer median 13.7%).
Valuation It trades at 55.4× forward earnings against a peer median of 23.2× (4th most expensive of 17).
Capital Return on invested capital runs 7.0 points below its cost of capital (10.0% WACC).
Next results Next results expected around 13 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥551M | CN¥355M | CN¥387M | CN¥410M | CN¥463M |
| Revenue growth | — | -8% | -6% | -12% | — |
| Gross profit | CN¥174M | CN¥71.9M | CN¥136M | CN¥154M | CN¥183M |
| EBITDA | n/a | CN¥52.5M | CN¥64.3M | CN¥123M | CN¥162M |
| Net income | CN¥13.5M | CN¥5.62M | CN¥53.1M | CN¥113M | CN¥162M |
| Free cash flow | -CN¥66.8M | -CN¥64.5M | CN¥22.0M | -CN¥91.7M | -CN¥26.0M |
| Capital expenditure | CN¥76.4M | CN¥92.7M | CN¥102M | CN¥198M | CN¥165M |
| Total debt | CN¥167M | CN¥31.4M | CN¥35.4M | CN¥429,469 | CN¥455,912 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301122.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -33.9% | -8.5% | lowest of 21 |
| 6-month return | +36.5% | -17.5% | 3rd highest of 21 |
| Distance from 52-week high | -40.8% | -38.3% | 10th lowest of 21 |
| Revenue growth (TTM) | +61.4% | +14.8% | 2nd highest of 21 |
| Operating margin | 0.3% | 13.7% | 5th lowest of 21 |
| Forward P/E | 55.4× | 23.2× | 4th most expensive of 17 |
| ROIC minus cost of capital | -7.0 pp | +3.5 pp | 3rd lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Caina Technology 301122.SZ | China | $721M | +36% | +61% | 0% | 55.4× | n/a | n/a |
| Doctorglasses Chain 300622.SZ | China | $710M | -22% | +6% | 14% | 22.8× | -3.4% | +15.7% |
| Shanghai Aladdin Biochemical Technology 688179.SS | China | $736M | -37% | +39% | 24% | 27.4× | 17.1% | +24.2% |
| SWS Hemodialysis Care 688410.SS | China | $706M | -11% | +31% | 19% | 23.5× | 16.2% | +25.9% |
| BMC Medical 301367.SZ | China | $737M | -17% | +37% | 17% | 18.7× | -1.5% | +15.6% |
| Beijing Aerospace Changfeng 600855.SS | China | $738M | -44% | -10% | -19% | n/a | n/a | n/a |
| Japan Lifeline 7575.T | Japan | $703M | +34% | +6% | 19% | 14.5× | -9.5% | +2.9% |
| InMode INMD | United States | $741M | -8% | +2% | 18% | 9.8× | -10.8% | +12.4% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $700M | -25% | +35% | 21% | 15.9× | -3.3% | +23.5% |
| Shanghai Runda Medical Technology 603108.SS | China | $744M | -36% | -12% | -2% | 20.5× | 20.3% | -0.2% |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $744M | -3% | +12% | 18% | 16.2× | -1.9% | +11.8% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $697M | +148% | -14% | 3% | n/a | 31.8% | -0.6% |
| Allmed Medical Products 002950.SZ | China | $747M | -32% | +14% | 8% | n/a | n/a | n/a |
| Shanghai Sanyou Medical 688085.SS | China | $692M | -23% | +15% | 4% | 50.0× | 29.0% | +6.8% |
| Shenzhen Lifotronic Technology 688389.SS | China | $692M | -14% | +14% | 13% | 29.9× | 11.6% | +13.3% |
| Sino Medical Sciences Technology 688108.SS | China | $753M | -41% | +22% | 19% | 60.0× | 27.9% | +9.9% |
| Livsmed 491000.KS | South Korea | $687M | -47% | +89% | -77% | n/a | n/a | n/a |
| Maccura Biotechnology 300463.SZ | China | $756M | -18% | -1% | -4% | 421.0× | 7.9% | -10.2% |
| Delcath Systems DCTH | United States | $685M | +75% | +38% | 5% | 358.9× | 33.4% | +120.2% |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $680M | -9% | +29% | 5% | 39.0× | 10.1% | +14.2% |
| Zylox-Tonbridge Medical Technology 2190.HK | Hong Kong | $768M | -16% | +39% | 25% | 14.4× | 3.8% | +105.8% |